SMW Free Realtime Trade Alerts -- Our Last 2 Trade Alerts were VII and NFEC, easy 40-75% wins in minutes, Join Today for FREE!!

Halozyme Therapeutics, Inc.
(NASDAQ : HALO)

( )
HALO After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
Loading HALO News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
0.91%81.791.6%$917.74m
BIIBBiogen Inc.
0.46%288.351.2%$563.58m
AMGNAmgen Inc.
1.80%170.681.2%$484.60m
CELGCelgene Corporation
1.82%108.111.1%$483.92m
REGNRegeneron Pharmaceuticals, Inc.
4.22%415.093.1%$314.35m
ALXNAlexion Pharmaceuticals, Inc.
2.47%129.782.6%$250.20m
BMRNBioMarin Pharmaceutical Inc.
6.60%98.093.9%$221.31m
TSROTESARO, Inc.
3.70%93.3818.0%$220.10m
ILMNIllumina, Inc.
8.10%162.255.1%$184.65m
VRTXVertex Pharmaceuticals Incorporated
1.08%96.011.7%$136.85m
MDVNMedivation, Inc.
-0.14%62.552.6%$124.28m
JUNOJuno Therapeutics, Inc.
-0.49%30.377.9%$105.68m
EXASExact Sciences Corporation
3.76%16.8228.8%$94.88m
AAgilent Technologies, Inc.
0.68%47.271.9%$89.23m
INCYIncyte Corporation
2.02%88.722.2%$76.74m

Company Profile

Halozyme Therapeutics, Inc. is a biopharmaceutical company, which focuses on developing and commercializing novel oncology therapies that target the tumor microenvironment. Its investigational drug PEGPH20, applies a unique approach to targeting solid tumors, allowing increased access of co-administered cancer drug therapies to the tumor. PEGPH20 is currently in development for metastatic pancreatic cancer and non-small cell lung cancer and has potential across additional cancers in combination with different types of cancer therapies. Halozyme Therapeutics was founded by Gregory Ian Frost in 1998 and is headquartered in San Diego, CA.